Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial.
Langefeld CD, Divers J, Pajewski NM, Hawfield AT, Reboussin DM, Bild DE, Kaysen GA, Kimmel PL, Raj DS, Ricardo AC, Wright JT Jr, Sedor JR, Rocco MV, Freedman BI; Systolic Blood Pressure Intervention Trial (SPRINT).
Langefeld CD, et al. Among authors: rocco mv.
Kidney Int. 2015 Jan;87(1):169-75. doi: 10.1038/ki.2014.254. Epub 2014 Jul 16.
Kidney Int. 2015.
PMID: 25029429
Free PMC article.